E-Folder - Business

Oracle Corporation is the number two software company in the world. It was founded in 1986 in USA and now has representatives in about 70 countries all over the world. Its main

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

competitors are Microsoft and IBM. Oracle consists of two businesses: software development and services. Corporation aims to provide its customers with business applications and

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

secure database programs.

This report is prepared with interest of the shareholders as the primary stakeholders in mind. The analysis will try to cover the areas of maximizat

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ion of the shareholders values.

Investors are mainly interested in liquidity and profitability of a company, what the risk factors are and what key issues the company is faci

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

g. How the management plans to handle these issues and what steps they are taking in relation to that. How they use their resources and what is their efficiency in maintaining

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

the resources in the future for their competitive advantage.

On June 9, 2003, Oracle commenced an unsolicited tender offer of approximately $5.1 billion for all the outstandi

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ng shares of common stock of PeopleSoft Inc. which is now revised to approximately 7.7 billion. In connection to the tender offer the US dept of justice filed a civil antitru

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

t lawsuit.

Strengths- They have sufficient cash on hand including internally available cash and investments, $1.5 billion revolving credit facility or issuance of securities

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

o pay offer price for all shares in offer.

Weaknesses- There are doubts about the sincerity of the bid and some consider it to be a publicity stunt. PeopleSoft’s CEO Craig Con

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

way is an ex-Oracle employee. He believes that the bid is a plan to wreck PeopleSoft’s business.

Opportunities- It can be a biggest step towards expansion by acquiring Peopl

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

Soft with its large customer base and one of the best application software. It will also remove one of their biggest competitors in the application software business and give

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

hem a competitive advantage to other application software competitors.

Threats- If they are not successful in the lawsuit, they won’t be able to acquire PeopleSoft and depart

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ment’s analysis may impact on their acquiring other companies. This lawsuit could result in substantial cost and divert the attention of the management. Even if they are succ

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ssful, difficulty in integrating with the core company is a main threat.

4.2 Competition

In their core database business Oracle was having a tough competition with IBM and M

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

crosoft which increased much more due to reduced price and improved quality offerings from competitors and decline in database software market. Oracle is planning to expand in

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

the highly competitive market of application software.

Strengths- They have a high customer base of their database and most of the application providers depend on their data

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ase area to base their applications on. Huge cash reserves and plans to invest highly in Research & Development to have competitive advantage.

Weaknesses- Their core business

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

of database software is already past its peak and there has been decline in this business. They don’t have much experience in other areas of software business and the market

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

perception is of a database and tools providing company.

Opportunities- With acquisition of PeopleSoft, Oracle will become No. 2 in the application software business and will

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ave a huge customer base.

Threats- Rapid technology changes and changing customer demands and reduced price offerings of the competitors are major threats facing the company

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/44724/e-folder-Oracle.html">Oracle</a>

BB link (for phorums):
[url=http://www.e-folder.org.ua/article/44724/e-folder-Oracle.html]Oracle[/url]

Finding a new teaching opportunity can be a daunting process. The result is that available teaching positions may be limited, and the competition for these positions fierce. A big part of the job search process is knowing where to look for teaching positions.

If home business requires patience, persistence, hard, regular work, skills and techniques that will have to be learnt online.. what is so differenct about it? What will ultimately keep one motivated....

Planning time to work ON your business, rather than IN your business, is absolutely crucial to the future growth and development of your business. Below is a proven time management strategy that will get you out of the client service rut and enable you to create the kind of business you truly want.

Tags

Links

E-Folder - Oracle

Related Articles: